William S. (Bill) Dalton will be the featured speaker at the University of Illinois Cancer Center’s Distinguished Lecture Series on Thursday, Nov. 21, from 1:30 p.m. to 2:30 p.m. in the UIC College of Medicine Research Building’s Moss Auditorium (Room 1020), 909 S. Wolcott Ave. Dalton will present “Moving from Reactive to Proactive Medicine Through Data Science and Collective Impact.”
Dalton, PhD, MD, is founder and executive chair of M2Gen, a national biotechnology subsidiary of the Moffitt Cancer Center, Tampa, Florida. He is a founding member of ORIEN (Oncology Research Information Exchange Network), a unique research partnership among North America’s top cancer centers that recognize collaboration and access to data are the keys to cancer discovery. Through ORIEN, founders Moffitt Cancer Center and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute is leveraging multiple data sources and matching patients to targeted treatments.
Dalton is past president, CEO and director of Moffitt Cancer Center, a National Cancer Institute-designated comprehensive cancer center. Prior to joining Moffitt, he served as dean of the University of Arizona College of Medicine. His research interested include the development of information systems to allow aggregation, organization, and sharing of patient data in real time to enhance the discovery and delivery of evidenced-base precision medicine.
For his leadership in the area of personalized medicine, Dalton was recognized as the 2010 recipient of the Personalized Medicine Coalition’s National Leadership in Personalized Medicine Award. Dalton’s basic and translational research interests focus on molecular mechanisms of drug resistance and drug discovery. His work has been printed in more than 200 publications, he serves on several editorial boards, and has numerous patents in the fields of drug discovery and computer/information networking.
Dalton has served on numerous not-for-profit boards, including the National Board of the Leukemia and Lymphoma Society, and is the past-chair of the Personalized Medicine Coalition. He currently serves as board chair of the Institute of Human and Machine Cognition, as well as past-president of the Association of American Cancer Institutes.
All University of Illinois Cancer Center members are encouraged to attend this informative seminar. A reception will follow Dalton’s lecture. RSVP here.